BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10599069)

  • 1. [A simple and rapid routine preparation of no-carrier added meta-I-123- and I-131-iodobenzylguanidine (I-123-MIBG and I-131-MIBG) for clinical nuclear medicine applications].
    Samnick S; Kirsch CM
    Nuklearmedizin; 1999; 38(7):292-6. PubMed ID: 10599069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved labelling of no-carrier-added 123I-MIBG and preliminary clinical evaluation in patients with ventricular arrhythmias.
    Samnick S; Bader JB; Müller M; Chapot C; Richter S; Schaefer A; Sax B; Kirsch CM
    Nucl Med Commun; 1999 Jun; 20(6):537-45. PubMed ID: 10451866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A convenient solution-phase method for the preparation of meta-iodobenzylguanidine in high effective specific activity.
    Donovan AC; Valliant JF
    Nucl Med Biol; 2008 Oct; 35(7):741-6. PubMed ID: 18848658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A convenient method for the preparation of radioiodinated meta-iodobenzylguanidine at a no-carrier-added level.
    Wang G; Chen Z; Wu E; Wang Y; Huang H
    J Labelled Comp Radiopharm; 2015; 58(11-12):442-4. PubMed ID: 26391308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No-carrier-added synthesis of a 4-methyl-substituted meta-iodobenzylguanidine analogue.
    Vaidyanathan G; Affleck DJ; Zalutsky MR
    Appl Radiat Isot; 2005 Mar; 62(3):435-40. PubMed ID: 15607920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-labeled MIBG derivatives: novel 99mTc complexes as myocardial imaging agents for sympathetic neurons.
    Zhuang ZP; Kung MP; Mu M; Hou C; Kung HF
    Bioconjug Chem; 1999; 10(2):159-68. PubMed ID: 10077463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of radioiodination of meta-iodobenzylguanidine (MIBG) catalysed by in situ generated Cu(I) and directly added Cu(II).
    Prabhakar G; Mehra KS; Ramamoorthy N; Chattopadhyay S; Oommen R; Narasimhan S; Nair NA; Gunasekaran S
    Appl Radiat Isot; 1999 Jun; 50(6):1011-4. PubMed ID: 10355103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
    Israel I; Brandau W; Farmakis G; Samnick S
    Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity.
    Verberne HJ; de Bruin K; Habraken JB; Somsen GA; Eersels JL; Moet F; Booij J; van Eck-Smit BL
    Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):483-90. PubMed ID: 16425032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a fast and high yield method for routine production of [(131) I]MIBG and investigation of its radiochemical stability for diagnosis and treatment uses.
    Davarpanah MR; Attar Nosrati S; Khoshhosn HA; Fazlali M; Kazemi Boudani M
    J Labelled Comp Radiopharm; 2013 Nov; 56(13):686-8. PubMed ID: 25196031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
    Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-iodobenzylguanidine and analogues: chemistry and biology.
    Vaidyanathan G
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):351-68. PubMed ID: 19088690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient batch preparation of high specific activity.
    Amartey JK; Al-Jammaz I; Lambrecht RM
    Appl Radiat Isot; 2001 May; 54(5):711-4. PubMed ID: 11258518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and efficient preparation of [123I]radiopharmaceuticals using a small HPLC (Rocket) column.
    Katsifis A; Papazian V; Jackson T; Loc'h C
    Appl Radiat Isot; 2006 Jan; 64(1):27-31. PubMed ID: 16129607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kit method for the high level synthesis of [211At]MABG.
    Vaidyanathan G; Affleck DJ; Alston KL; Zhao XG; Hens M; Hunter DH; Babich J; Zalutsky MR
    Bioorg Med Chem; 2007 May; 15(10):3430-6. PubMed ID: 17387017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of specific activity on cardiac uptake of iodine-123-MIBG.
    Farahati J; Bier D; Scheubeck M; Lassmann M; Schelper LF; Grelle I; Hanscheid H; Biko J; Graefe KH; Reiners C
    J Nucl Med; 1997 Mar; 38(3):447-51. PubMed ID: 9074536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET imaging of norepinephrine transporter-expressing tumors using 76Br-meta-bromobenzylguanidine.
    Watanabe S; Hanaoka H; Liang JX; Iida Y; Endo K; Ishioka NS
    J Nucl Med; 2010 Sep; 51(9):1472-9. PubMed ID: 20720048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.
    Barrett JA; Joyal JL; Hillier SM; Maresca KP; Femia FJ; Kronauge JF; Boyd M; Mairs RJ; Babich JW
    Cancer Biother Radiopharm; 2010 Jun; 25(3):299-308. PubMed ID: 20578835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ESI-MS for semi-quantitative estimation of inactive precursor in no-carrier-added
    Mathur A; Das S; Sakhare N; Sachdev SS
    J Pharm Biomed Anal; 2019 Feb; 165():261-267. PubMed ID: 30562709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
    Vaidyanathan G; Zalutsky MR
    Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.